Pharmalot By Ed Silverman Two dozen states side with HHS in its raucous dispute with pharma over a drug discount program
Biotech By Allison DeAngelis Apollo acquires minority stake in Sofinnova, extending private equity dealmaking in life sciences
Pharmalot By Ed Silverman Greece plans to go to court to seek compensation from Novartis over a bribery scandal
Pharmalot By Ed Silverman Pharmalittle: FDA OKs new type of diabetes drug from Lilly; Early-stage biotechs are juicy targets for M&A surge
Health By Helen Branswell Patient Zero in AIDS crisis was misidentified, study says, rewriting early history of virus
In the Lab By Shayla Love Genetic fossil-hunters dig through HIV’s long history for clues to new treatments
Special Report By Helen Branswell History credits this man with discovering Ebola on his own. History is wrong
Quick Take By Ike Swetlitz A serious stomach bug: Norovirus costs billions of dollars of lost productivity
Health By Andrew Joseph Billboards in Brazil have been rigged to lure and kill Zika-carrying mosquitoes
Health By Andrew Joseph Does getting Zika raise a woman’s risk of birth defects in future pregnancies?
In the Lab By Helen Branswell A disease detective hunts pathogens with a photographic memory — and a genius mind
Health By Associated Press Worry over Zika virus leads El Salvador to urge two-year delay in pregnancies